ReShape Lifesciences (RSLS) has had the highest return since January 1, 2025 by a US stock, returning 92,400%.

ASSET	% RETURN
ReShape Lifesciences (RSLS)	92,400%
Regencell Bioscience (RGC)	7,104.92%
Mobile Global Esports (MGAM)	1,775%
Asset Entities Inc Class B Common Stock (ASST)	1,524%
Janover Inc Common Stock (JNVR)	1,491.72%
Diginex Limited Ordinary Shares (DGNX)	1,440.61%
Abits (ABTS)	1,218.18%
Splash Beverage Group, Inc WT (SBEV.WT)	837.5%
Oncology Institute (TOI)	815.03%
Webull Corporation Warrants (BULLW)	804.09%
HCM II Acquisition (HONDW)	749.14%
Oncology Institute (TOIIW)	682.14%
Top KingWin (WAI)	543.27%
Aimfinity Investment Corp I Warrant (AIMAW)	542.86%
Dominari (DOMH)	536.08%
Global Interactive Technologies (GITS)	526.56%
Oriental Culture Holding (OCG)	505.04%
Protagenic Therapeutics (PTIX)	487.9%
Marblegate Acquisition Corp Warrant (GATEW)	466.67%
TMC the metals company Inc Warrants (TMCWW)	456.6%
Arena (AREN)	415.22%
Regulus Therapeutics (RGLS)	391.88%
NETCLASS TECHNOLOGY INC Class A Ordinary Shares (NTCL)	384.59%
Yoshiharu Global (YOSH)	372.73%
Webull Corporation Incentive Warrant (BULLZ)	352.38%